Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection

NCT02806674 is registered in ClinicalTrials.gov with The University of Hong Kong-Shenzhen Hospital as lead sponsor.

NCT NCT02806674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02806674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection
Lead sponsor
The University of Hong Kong-Shenzhen Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2016
Completion date
December 31, 2019
Enrollment
1,845 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

gastritis